Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer

Cécile Evin, Nathalie Lassau, Corinne Balleyguier, Tarek Assi, Samy Ammari

Open source

DOI
10.3390/diagnostics12061369
Published
2022-06-02
Container
Diagnostics
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics12061369,
  title = {Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer},
  author = {Cécile Evin and Nathalie Lassau and Corinne Balleyguier and Tarek Assi and Samy Ammari},
  year = {2022},
  journal = {Diagnostics},
  doi = {10.3390/diagnostics12061369},
  url = {https://doi.org/10.3390/diagnostics12061369}
}

RIS

TY  - JOUR
TI  - Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer
AU  - Cécile Evin
AU  - Nathalie Lassau
AU  - Corinne Balleyguier
AU  - Tarek Assi
AU  - Samy Ammari
PY  - 2022
JO  - Diagnostics
DO  - 10.3390/diagnostics12061369
UR  - https://doi.org/10.3390/diagnostics12061369
ER  - 

APA

Evin, C., Lassau, N., Balleyguier, C., Assi, T., & Ammari, S. (2022). Posterior Reversible Encephalopathy Syndrome Following Chemotherapy and Immune Checkpoint Inhibitor Combination in a Patient with Small-Cell Lung Cancer. Diagnostics. https://doi.org/10.3390/diagnostics12061369

Source records